Long-term survival of female patients with genital cancer
Author Information
Author(s): J.L. Haybittle, E.M. Kingsley-Pillers
Primary Institution: MRC Cancer Trials Office
Hypothesis
Is there evidence for clinical cure in patients suffering from cancer of the cervix, corpus, or ovary?
Conclusion
Long-term survivors of genital cancer have mortality rates similar to a normal population, but still face a higher risk of dying from their original cancer.
Supporting Evidence
- Long-term survivors had mortality rates similar to a normal population.
- Death rates from other cancers were slightly increased in cervix patients.
- Statistical cure was observed with 45%, 55%, and 22% for cervix, corpus, and ovary cancers respectively.
Takeaway
Women who survive genital cancer live as long as other women their age, but they are still more likely to die from their cancer.
Methodology
The study included all patients registered with cancer of the cervix, corpus, or ovary from 1960 to 1979, with follow-ups ranging from 6 to 25 years.
Potential Biases
There may be risks of bias due to the reliance on historical data and potential inaccuracies in death certification.
Limitations
The study is retrospective and may be influenced by changes in treatment techniques over time.
Participant Demographics
Female patients with genital cancer registered in Cambridge between 1960 and 1979.
Statistical Information
P-Value
p<0.001
Confidence Interval
95% confidence limits provided for various death ratios.
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website